Live tape
Top 8, mentions 7d8,657GOOGL1,668 mentions▲ +0.04SNDK1,265 mentions▲ +0.10MRNA1,259 mentions▲ +0.09META1,109 mentions▲ +0.03NVDA1,028 mentions▲ +0.08SPCX889 mentions▲ +0.08NBIS743 mentions▲ +0.09MSFT696 mentions▲ +0.06

Equity · Financial Services

FRHC

Freedom Holdings Corp. · NasdaqCM

$153 +2.00% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart
Our own end-of-day closes 38 sessions
$180 $120 22 May 17 Jul

The line runs $144 on 22 May through $153 on 17 July, on a scale from $120 to $180. Days the market did not trade hold the previous close, flat.

The chart above plots the price of FRHC over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 38 sessions over that window: $144 on 22 May 2026 through $153 on 17 July 2026.

Market cap $9.8B
P/E (TTM) 50.8
52-week range $112 – $190
Avg volume 27.8K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 19, 2026

FRHC insider trades

SEC Form 4 · last 90 days · newest reported trade 13 Aug 2026
Open-market buys 0
Open-market sells 4
Net sold $2.70M
Non-trade filings 5
Date Insider Type Shares Value
13 Aug 2026 Tukanov Renat CHIEF TECHNOLOGY OFFICER Sell 2,700 $408K
22 Jun 2026 Gamble Andrew Director Sell 357 $50K
22 Jun 2026 Tukanov Renat CHIEF TECHNOLOGY OFFICER Sell 1,800 $253K
04 Jun 2026 Yerdessov Azamat Freedom Life Chief Exec. Ofc. Sell 12,800 $1.99M

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
11 Jun 2026 Vogeleer Philippe J.R. Director Award 677
11 Jun 2026 Gamble Andrew Director Award 677
11 Jun 2026 Williams Amber Director Award 677
11 Jun 2026 CHERDABAYEV BORIS Director Award 677
29 May 2026 Yerdessov Azamat Freedom Life Chief Exec. Ofc. Award 83,749

FRHC reported financials

SEC EDGAR XBRL

FRHC reported revenue of $97.4M for the fiscal year ended 31 Mar 2026. Net income over the same period was $153.3M.

Figure Reported Period
Revenue $97.4M 31 Mar 2026 fiscal year
Net income $153.3M 31 Mar 2026 fiscal year
Diluted EPS $2.51 31 Mar 2026 fiscal year
Total assets $14.0B 30 Jun 2026 at period end
Total equity $1.5B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

FRHC earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q1 2027 $0.52 $733M
31 Mar 2026 FY 2026 $2.51 $2.19B
31 Dec 2025 Q3 2026 $1.25 $629M
30 Sep 2025 Q2 2026 $0.63 $526M
30 Jun 2025 Q1 2026 $0.61 $524M
31 Mar 2025 FY 2025 $1.26 $2.00B
31 Dec 2024 Q3 2025 $1.29 $665M
30 Sep 2024 Q2 2025 $1.89 $586M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

FRHC institutional holders

SEC Form 13F

5 of the 45 institutional funds we track reported a FRHC position for the quarter ended 30 Jun 2026 — a combined $20.0M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
AQR Capital Management Held (±25%) +5.4% shares 115,495 $14.9M
Millennium Management Trimmed −56.7% shares 26,000 $3.4M
Renaissance Technologies New position 6,100 $796K
Point72 Asset Management New position 4,732 $617K
Balyasny Asset Management Trimmed −33.6% shares 2,385 $311K

Source: SEC EDGAR 13F filings

FRHC fails-to-deliver

SEC CNS data

On 31 Jul 2026, 4,737 shares of FRHC failed to deliver (about $735K) — the latest of 6 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
31 Jul 2026 4,737 $735K 0.007%
30 Jul 2026 1,476 $219K 0.002%
29 Jul 2026 221 $34K <0.001%
28 Jul 2026 1,393 $218K 0.002%
27 Jul 2026 4,238 $640K 0.007%
24 Jul 2026 6,175 $954K 0.010%
22 Jul 2026 2,902 $464K 0.005%
21 Jul 2026 16,591 $2.6M 0.026%
20 Jul 2026 541 $83K 0.001%
17 Jul 2026 358 $54K 0.001%
16 Jul 2026 3,854 $608K 0.006%
15 Jul 2026 6,851 $1.0M 0.011%
14 Jul 2026 2,058 $331K 0.003%
13 Jul 2026 9,117 $1.5M 0.014%

Source: SEC fails-to-deliver (CNS) data